Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03685188 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oxycodone and Sufentanil for Analgesia in Hip Surgery

StatusEnrolling by Invitation
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 8, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 29 words
    • Secondary endpoints: 13 to 16
    v7
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Study completion date: Jul 31, 2024 to Jul 31, 2025
    • Secondary endpoints: 14 to 13
    v6
  3. Primary endpoints: 2 to 1
    • Secondary endpoints: 13 to 14
    v5
  4. Primary completion date: Dec 31, 2021 to Dec 31, 2023
    • Study completion date: Jul 31, 2022 to Jul 31, 2024
    v4
  5. Primary endpoints: 1 to 2
    • Secondary endpoints: 8 to 13
    • Eligibility criteria expanded, about 1 word
    v3
  6. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
We design this randomized controlled trial to compare the safety and efficacy of Oxycodone and Sufentanil for postoperative patient-controlled analgesia in patients undergoing hip surgery, with a view to finding the optimal postoperative analgesic regime with fewer adverse reactions and promoting patients' rehabilitation.
Trial Details
NCT Number NCT03685188
Lead Sponsor West China Hospital
Conditions
(from sponsor)		 Analgesia, Patient-Controlled
Related terms Agnosia
Enrollment 570 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov